MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, BRTX has $4,640,279 in assets. $3,112,679 in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
235.33%
Quick Ratio
235.33%
Cash Ratio
192.78%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Intangible assets, net
    • Investments held in marketable s...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Common stock, 0.0001 par value 7...

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
3,112,679 1,511,188 602,444 1,555,251
Investments held in marketable securities
479,351 1,441,734 3,887,383 5,825,685
Accounts receivable
13,300 15,500 13,400 15,000
Prepaid expenses and other current assets
194,378 168,440 204,237 201,871
Total current assets
3,799,708 3,136,862 4,707,464 7,597,807
Deferred offering costs
-49,808 69,066 0
Property plant and equipment gross
-1,590,141 --
Less accumulated depreciation
-1,231,374 --
Property and equipment, net
328,810 358,767 309,498 339,681
Intangible assets, net
511,761 534,198 556,634 579,071
Total assets
4,640,279 4,079,635 5,642,662 8,516,559
Warrant liabilities
-1,399,349 1,968,315 2,580,379
Accounts payable
666,898 1,341,495 859,898 609,931
Accrued expenses and other current liabilities
947,739 982,047 607,470 480,925
Total current liabilities
1,614,637 3,722,891 3,435,683 3,671,235
Preferred stock, 0.01 par value 20,000,000 shares authorized series b convertible preferred stock 1,543,158 shares designated, 1,398,158 shares issued and outstanding at september 30, 2025 and december 31, 2024
--13,982 13,982
Statementclassofstockaxis
-13,982 --
Common stock, 0.0001 par value 75,000,000 shares authorized 25,478,170 and8,876,242 sharesissued and outstanding at march 31, 2026 and december 31, 2025, respectively
2,548 887 797 797
Total liabilities
---3,671,235
Additional paid-in capital
175,098,189 170,262,565 168,905,254 168,505,322
Accumulated deficit
-172,075,095 -169,920,690 -166,713,054 -163,674,777
Total stockholders equity
3,025,642 356,744 2,206,979 4,845,324
Total liabilities and stockholders equity
4,640,279 4,079,635 5,642,662 8,516,559
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$3,112,679 Investments held inmarketable securities$479,351 Prepaid expenses andother current assets$194,378 Accounts receivable$13,300 Total current assets$3,799,708 Intangible assets, net$511,761 Property and equipment,net$328,810 Total assets$4,640,279 Total liabilities andstockholders equity$4,640,279 Total stockholdersequity$3,025,642 Total currentliabilities$1,614,637 Accumulated deficit-$172,075,095 Additional paid-in capital$175,098,189 Accrued expenses andother current...$947,739 Accounts payable$666,898 Common stock, 0.0001par value...$2,548

BioRestorative Therapies, Inc. (BRTX)

BioRestorative Therapies, Inc. (BRTX)